Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Becker · SciRah

Researcher profile · Semantic Scholar

S. Becker

Share profile

S. Becker — researcher profile on SciRah

h-index: 23
Works: 54
Citations: 1,788

Most-cited papers

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.
R. Mitsuyasu, T. Merigan, A. Carr, J. Zack +28 more
2009Nature Medicine261 citations Open access
Semantic Scholar
Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection
K. Squires, A. Pozniak, G. Pierone, C. Steinhart +8 more
2003Annals of Internal Medicine180 citations
Semantic Scholar
Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects
N. Stone, Shelia B. Dunaway, C. Flexner, C. Tierney +12 more
2007Antimicrobial Agents and Chemotherapy121 citations Open access
Semantic Scholar
HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study.
S. Becker, G. Fusco, J. Fusco, Rukmini B. Balu +3 more
2004Clinical Infectious Diseases98 citations Open access
Semantic Scholar
Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.
P. Gilbert, J. Berger, D. Stablein, S. Becker +4 more
2011Journal of Infectious Diseases96 citations Open access
Semantic Scholar
Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.
G. Moyle, E. Dejesus, M. Boffito, R. Wong +6 more
2009Clinical Infectious Diseases76 citations Open access
Semantic Scholar
A Controlled Phase Ii Trial Assessing Three Doses of Enfuvirtide (T-20) in Combination with Abacavir, Amprenavir, Ritonavir and Efavirenz in Non-Nucleoside Reverse Transcriptase Inhibitor-Naive HIV-Infected Adults
J. Lalezari, E. Dejesus, D. Northfelt, G. Richmond +15 more
2002Antiviral Therapy68 citations Open access
Semantic Scholar
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection
J. Eron, Ellen S. Yetzer, P. Ruane, S. Becker +4 more
2000AIDS (London)66 citations Open access
Semantic Scholar
Young HIV-infected adults are at greater risk for medication nonadherence.
S. Becker, C. Dezii, Beth Burtcel, H. Kawabata +1 more
2002MedGenMed62 citations
Semantic Scholar
Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients.
R. Wurtz, D. Abrams, S. Becker, Mark A. Jacobson +2 more
1989The Lancet55 citations
Semantic Scholar
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities
Susan C. Kim, S. Becker, C. Dieffenbach, B. Hanewall +9 more
2010Journal of the International AIDS Society49 citations Open access
Semantic Scholar
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients
J. Sterne, M. May, C. Sabin, Andrew N. Phillips +496 more
2007Journal of Acquired Immune Deficiency Syndromes49 citations Open access
Semantic Scholar
Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus
J. Munakata, J. Benner, S. Becker, C. Dezii +2 more
2006Medical Care46 citations
Semantic Scholar
Liver toxicity in epidemiological cohorts.
S. Becker
2004Clinical Infectious Diseases46 citations
Semantic Scholar
New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents
M. Boffito, A. Jackson, A. Owen, S. Becker
2013Drugs44 citations
Semantic Scholar
Thymidine Analog and Multinucleoside Resistance Mutations Are Associated with Decreased Phenotypic Susceptibility to Stavudine in HIV Type 1 Isolated from Zidovudine-Naive Patients Experiencing Viremia on Stavudine-Containing Regimens
Lisa L. Ross, A. Scarsella, Stephen Raffanti, Keith Henry +7 more
2001AIDS Research and Human Retroviruses43 citations
Semantic Scholar
CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.
T. Kakuda, P. Anderson, S. Becker
2004AIDS (London)40 citations
Semantic Scholar
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.
J. Romano, A. Kashuba, S. Becker, J. Cummins +2 more
2013AIDS Research and Human Retroviruses29 citations Open access
Semantic Scholar
Zidovudine and Stavudine Sequencing in HIV Treatment Planning: Findings From the CHORUS HIV Cohort
S. Becker, S. Raffanti, N. Hansen, J. Fusco +4 more
2001Journal of Acquired Immune Deficiency Syndromes27 citations Open access
Semantic Scholar
Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus
R. Mitsuyasu, T. Merigan, A. Carr, J. Zack +28 more
2009Nature Medicine25 citations Open access
Semantic Scholar
Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers
Ying-Jun Cao, C. Flexner, Shelia B. Dunaway, J. Park +8 more
2008Antimicrobial Agents and Chemotherapy24 citations Open access
Semantic Scholar
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus.
S. Becker, Alvan. Fisher, C. Flexner, John G. Gerber +4 more
2001Journal of Acquired Immune Deficiency Syndromes24 citations
Semantic Scholar
Fosamprenavir: advancing HIV protease inhibitor treatment options
S. Becker, L. Thornton
2004Expert Opinion on Pharmacotherapy23 citations
Semantic Scholar
The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy
S. Becker
2003Expert Opinion on Investigational Drugs23 citations
Semantic Scholar
Treatment as prevention: translating efficacy trial results to population effectiveness.
G. Garnett, S. Becker, S. Bertozzi
2012Current Opinion in HIV and AIDS21 citations
Semantic Scholar
Implications of HIV PrEP Trials Results
F. Veronese, P. Anton, C. Fletcher, V. DeGruttola +4 more
2011AIDS Research and Human Retroviruses21 citations Open access
Semantic Scholar
Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers
Myaing M. Nyunt, S. Becker, R. Macfarland, Priscilla Chee +4 more
2008Journal of Acquired Immune Deficiency Syndromes21 citations Open access
Semantic Scholar
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen.
D. W. Cameron, S. Becker, M. King, B. D. da Silva +6 more
2007Journal of Antimicrobial Chemotherapy19 citations Open access
Semantic Scholar
Atazanavir: improving the HIV protease inhibitor class
S. Becker
2003Expert Review of Anti-Infective Therapy17 citations
Semantic Scholar
Pharmacokinetics of Saquinavir With Atazanavir or Low‐Dose Ritonavir Administered Once Daily (ASPIRE I) or Twice Daily (ASPIRE II) in Seronegative Volunteers
J. King, T. Kakuda, Sunita Paul, Man-Ming Tse +2 more
2007Journal of clinical pharmacology15 citations
Semantic Scholar
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort.
S. Becker, S. Raffanti, N. Hansen, J. Fusco +4 more
200115 citations
Semantic Scholar
Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial
W. D. Venter, A. Kambugu, M. Chersich, S. Becker +12 more
2018Journal of Acquired Immune Deficiency Syndromes14 citations Open access
Semantic Scholar
Human immunodeficiency virus type-1 Vpu inhibitor, BIT225, in combination with 3-drug antiretroviral therapy modulates inflammation and immune cells functions.
C. Luscombe, A. Avihingsanon, K. Supparatpinyo, S. Gatechompol +6 more
2020Journal of Infectious Diseases13 citations
Semantic Scholar
Identifying Key Drivers of the Impact of an HIV Cure Intervention in Sub-Saharan Africa
A. Phillips, V. Cambiano, P. Revill, F. Nakagawa +11 more
2016Journal of Infectious Diseases13 citations Open access
Semantic Scholar
Erratum: Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection (AIDS (2000) 14 (671-681))
J. Eron, Ellen S. Yetzer, P. Ruane, S. Becker +4 more
20009 citations
Semantic Scholar
Interindividual variability in the effect of atazanavir and saquinavir on the expression of lymphocyte P-glycoprotein.
L. Chinn, J. Gow, Man-Ming Tse, S. Becker +1 more
2007Journal of Antimicrobial Chemotherapy8 citations Open access
Semantic Scholar
Disease progression in HIV-infected patients treated with stavudine vs. zidovudine.
A. Justice, D. Stein, G. Fusco, B. Sherrill +5 more
2004Journal of Clinical Epidemiology8 citations
Semantic Scholar
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210
V. Johnson, Y. Cramer, S. Rosenkranz, S. Becker +21 more
2019AIDS Research and Human Retroviruses7 citations Open access
Semantic Scholar
Effect of Low-Dose Ritonavir on the Pharmacokinetics of the CXCR 4 Antagonist AMD 070 in Healthy Volunteers †
Ying-Jun Cao, C. Flexner, Shelia B. Dunaway, J. Park +8 more
20084 citations
Semantic Scholar
Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects
N. Stone, Shelia B. Dunaway, C. Flexner, C. Tierney +12 more
2007Antimicrobial Agents and Chemotherapy2 citations Open access
Semantic Scholar
Delivering Cost-Effective HIV Patient Care: The Experience of a Large San Francisco Independent Physician Association
S. Becker
20012 citations
Semantic Scholar
New targets, new drugs, failed trials and the need for more information.
S. Becker
2004Positively aware : the monthly journal of the Test Positive Aware Network1 citations
Semantic Scholar
AC4 CLINICAL AND ECONOMIC OUTCOMES OF NON-ADHERENCE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV
J. Munakata, J. Benner, S. Becker, Christopher M. Dezii +2 more
20041 citations Open access
Semantic Scholar
Meeting reportPlanning for pre-exposure prophylaxis to prevent HIV transmission : challenges and opportunities
Susan C. Kim, S. Becker, C. Dieffenbach, B. Hanewall +9 more
20180 citations
Semantic Scholar
Defining Antiviral Potency: IC
S. Becker
20080 citations
Semantic Scholar
New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.
S. Becker
2007AIDS treatment news0 citations
Semantic Scholar
OII‐B‐4
L. Chinn, J. Gow, S. Becker, Man-Ming Tse +1 more
20060 citations
Semantic Scholar
Disease Progression in HIV-Infected Patients Treated with Stavudine versus Zidovudine Containing Regimens in the CHORUS Cohort
A. Justice, D. Stein, G. Fusco, E. Sherrill +5 more
20030 citations
Semantic Scholar
Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Exploring once-daily tenofovir + 3TC + abacavir: an argument for clinical-trials-based data.
S. Becker, Judith Feinberg
2003AIDS Clinical Care0 citations
Semantic Scholar
Background: Resistance to antiretroviral agents remains a lead- ing cause of treatment failure for patients infected with HIV-1.
K. Squires, A. Pozniak, C. Steinhart, D. Berger +7 more
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Macfarland×6
Invite
R. Macfarland — researcher profile on SciRah
G. Calandra×5
Invite
G. Calandra — researcher profile on SciRah
K. Klingman×5
Invite
K. Klingman — researcher profile on SciRah
C. Hendrix×5
Invite
C. Hendrix — researcher profile on SciRah

×5

Invite

G. Fusco — researcher profile on SciRah

Shelia B. Dunaway×4

Invite

Shelia B. Dunaway — researcher profile on SciRah

Invite

C. Flexner — researcher profile on SciRah

Ying-Jun Cao×4

Invite

Ying-Jun Cao — researcher profile on SciRah

Ilene P. Wiggins×4

Invite

Ilene P. Wiggins — researcher profile on SciRah

Jeanne Conley×4

Invite

Jeanne Conley — researcher profile on SciRah

Invite

J. Park — researcher profile on SciRah

Invite

J. Fusco — researcher profile on SciRah